Sort by
Keyphrases
Adenoviral Transduction
9%
Adult Humans
9%
Akt Kinase
9%
Akt Phosphorylation
9%
AKT1
100%
Binding Site
9%
Cardiac Tissue
9%
Chimera
9%
Disease States
9%
DNA Binding
9%
Dominant Negative
18%
Expression Vector
9%
Extracellular Matrix
9%
Fibronectin
100%
Fibrosis
9%
Gene Activity
9%
Human Cardiac Fibroblasts
100%
IL-1 Receptor-associated Kinase 1 (IRAK1)
9%
Interleukin
9%
Interleukin-18 (IL-18)
100%
Kinase Activity
18%
LY294002
9%
MRNA Expression
9%
Myeloid Differentiation Factor 88 (MyD88)
9%
Myocardial Failure
9%
Myocardial Hypertrophy
18%
Myocardial Remodeling
9%
Negative Expressions
9%
Neutralizing Antibodies
9%
NF-B
100%
Overexpression
9%
Phosphoinositide 3-kinase (PI3K)
9%
Reporter Gene
9%
RNA Interference
9%
Transcription Expression
9%
Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6)
9%
Wortmannin
9%
Biochemistry, Genetics and Molecular Biology
Binding Affinity
9%
Binding Site
9%
Cytokine
18%
DNA Binding
9%
Expression Vector
9%
Fibroblast
100%
Fibronectin
100%
Gene Activity
9%
Interleukin
9%
Interleukin 18
100%
IRAK1
9%
Kinase
9%
LY294002
9%
Messenger RNA
9%
Neutralizing Antibody
9%
Phosphoinositide 3-Kinase
9%
Phosphotransferase
9%
Promoter Region
18%
Reporter Gene
9%
RNAI
9%
TRAF6
9%
Transcription
18%
Immunology and Microbiology
Binding Affinity
9%
Binding Site
9%
Cytokine
18%
DNA Binding
9%
Expression Vector
9%
Extracellular Matrix
9%
Fibroblast
100%
Fibronectin
100%
Gene Activity
9%
Interleukin
9%
Interleukin 18
100%
IRAK1
9%
Neutralizing Antibody
9%
Promoter Region
18%
Reporter Gene
9%
RNAI
9%
Pharmacology, Toxicology and Pharmaceutical Science
2 Morpholino 8 Phenylchromone
9%
Binding Site
9%
Congestive Heart Failure
9%
Cytokine
18%
Disease
9%
DNA B
9%
Fibronectin
100%
Fibrosis
9%
Heart Ventricle Hypertrophy
18%
Interleukin 18
100%
Messenger RNA
9%
Myeloid Differentiation Factor 88
9%
Neutralizing Antibody
9%
Phosphatidylinositol 3 Kinase
9%
Phosphotransferase
9%
Tumor Necrosis Factor Receptor Associated Factor 6
9%
Wortmannin
9%